Alzheimer Disease

Showing NaN - NaN of 37

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)

Recruiting
  • Alzheimer Disease
  • +2 more
  • Birmingham, Alabama
  • +143 more
Jan 31, 2023

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Enrolling by invitation
  • Diabetes
  • +4 more
    • Phoenix, Arizona
    • +26 more
    Jan 19, 2023

    Mild Cognitive Impairment, Alzheimer Trial in United States (Donanemab, Aducanumab)

    Active, not recruiting
    • Mild Cognitive Impairment
    • Alzheimer Disease
    • Fullerton, California
    • +30 more
    Jan 18, 2023

    Alzheimer Trial in Worldwide (LY3372689, Placebo)

    Active, not recruiting
    • Alzheimer Disease
    • Canoga Park, California
    • +70 more
    Jan 18, 2023

    Alzheimer Trial in Canada, United States (Donanemab, Placebo, LY3202626)

    Completed
    • Alzheimer Disease
    • Phoenix, Arizona
    • +60 more
    Sep 19, 2022

    Alzheimer Trial in Japan, Puerto Rico, United States (Donanemab, Placebo)

    Recruiting
    • Alzheimer Disease
    • Birmingham, Alabama
    • +215 more
    Aug 9, 2022

    Alzheimer Trial in Worldwide (Gantenerumab, Placebo)

    Recruiting
    • Alzheimer Disease
    • Tucson, Arizona
    • +247 more
    Jul 29, 2022

    Traumatic Brain Injury, Alzheimer, Veterans Trial in Indianapolis (ABC ANSWERS, Control)

    Active, not recruiting
    • Traumatic Brain Injury
    • +5 more
    • ABC ANSWERS
    • Control
    • Indianapolis, Indiana
      Richard L. Roudebush VAMC
    Jul 20, 2022

    Alzheimer, Dementia, Brain Diseases Trial in Canada, United States (No Intervention, donanemab)

    Active, not recruiting
    • Alzheimer Disease
    • +4 more
    • Phoenix, Arizona
    • +27 more
    May 25, 2022

    Alzheimer Trial in La Jolla, Indianapolis, London (E2814)

    Active, not recruiting
    • Alzheimer Disease
    • La Jolla, California
    • +2 more
    May 24, 2022

    Alzheimer Trial in Worldwide (Donanemab, Placebo)

    Active, not recruiting
    • Alzheimer Disease
    • Hoover, Alabama
    • +282 more
    Apr 6, 2022

    Longitudinal Early-onset Alzheimer's Disease Study Protocol

    Recruiting
    • Early Onset Alzheimer Disease
    • +2 more
    • Sun City, Arizona
    • +18 more
    Mar 15, 2022

    Alzheimer Trial in Indianapolis (UPLIFT-AD)

    Recruiting
    • Alzheimer Disease
    • UPLIFT-AD
    • Indianapolis, Indiana
      American Senior Communities
    Mar 8, 2022

    Alzheimer Trial in Australia, United States (ATH-1017)

    Enrolling by invitation
    • Alzheimer Disease
    • Sun City, Arizona
    • +35 more
    Feb 28, 2022

    Alzheimer Trial in United States (troriluzole, Placebo oral capsule)

    Completed
    • Alzheimer Disease
    • Phoenix, Arizona
    • +43 more
    Feb 15, 2022

    Alzheimer, Mild Cognitive Impairment Trial in Indianapolis, Boston, Jamaica Plain (Pramlintide challenge test)

    Recruiting
    • Alzheimer Disease
    • Mild Cognitive Impairment
    • Pramlintide challenge test
    • Indianapolis, Indiana
    • +2 more
    Jan 27, 2022

    Alzheimer Trial in Canada, United States (Azeliragon, Placebo)

    Terminated
    • Alzheimer Disease
    • Tucson, Arizona
    • +32 more
    Dec 21, 2021

    Alzheimer Trial in Worldwide (GV-971, Placebo)

    Recruiting
    • Alzheimer Disease
    • Gilbert, Arizona
    • +170 more
    Dec 10, 2021

    Late Onset Alzheimer's Disease

    Recruiting
    • Alzheimer Disease
    • Blood Draw
    • Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test
    • Washington, District of Columbia
    • +11 more
    Aug 11, 2021

    Dementia, Dementia, Vascular, Dementia With Lewy Bodies Trial in United States (ADRD-PC Program)

    Enrolling by invitation
    • Dementia
    • +7 more
    • ADRD-PC Program
    • Denver, Colorado
    • +3 more
    Jul 29, 2021

    Alzheimer Trial in United States (CAD106)

    Completed
    • Alzheimer Disease
    • CAD106
    • Costa Mesa, California
    • +7 more
    Dec 11, 2020

    Alzheimer Trial in Canada, United States (Placebo Control, ELND005)

    Completed
    • Alzheimer Disease
    • Phoenix, Arizona
    • +61 more
    Oct 17, 2019

    Alzheimer Trial in United States (Crenezumab dose level 1, Crenezumab dose level 2, Crenezumb dose level 3)

    Completed
    • Alzheimer Disease
    • Crenezumab dose level 1
    • +3 more
    • Phoenix, Arizona
    • +12 more
    Jul 23, 2019

    Alzheimer Trial in Worldwide (Placebo, BI 409306, Donepezil)

    Completed
    • Alzheimer Disease
    • Placebo
    • +2 more
    • Sherman Oaks, California
    • +59 more
    Oct 18, 2018

    Alzheimer Trial in United States ([18F]NAV4694)

    Unknown status
    • Alzheimer Disease
    • New Haven, Connecticut
    • +6 more
    Mar 29, 2016